Dual Inhibition of Both the Epidermal Growth Factor Receptor and erbB2 Effectively Inhibits the Promotion of Skin Tumors During Two-Stage Carcinogenesis

Cancer Prevention Research - United States
doi 10.1158/1940-6207.capr-10-0010
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Honokiol Inhibits Epidermal Growth Factor Receptor Signaling and Enhances the Antitumor Effects of Epidermal Growth Factor Receptor Inhibitors

Clinical Cancer Research
Cancer ResearchOncology
2010English

Pertuzumab Increases Epidermal Growth Factor Receptor Down-Regulation by Counteracting Epidermal Growth Factor Receptor-ErbB2 Heterodimerization

Molecular Cancer Therapeutics
Cancer ResearchOncology
2009English

Quantitation of the Effect of ErbB2 on Epidermal Growth Factor Receptor Binding and Dimerization

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2012English

Activation of the Epidermal Growth Factor Receptor Promotes Lymphangiogenesis in the Skin

Journal of Dermatological Science
DermatologyBiochemistryMolecular Biology
2013English

Epidermal Growth Factor Receptor Inhibition Strategies in Oncology

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2004English

Dual Epidermal Growth Factor Inhibition and Multi Targeted Epigenetic Therapy (MTET)

Journal of Cancer Therapy
2018English

Clinical Significance of the Mutant Epidermal Growth Factor Receptor "ΔEGFR" in Astrocytic Tumors

Japanese Journal of Neurosurgery
SurgeryNeurology
2003English

Specific, Irreversible Inactivation of the Epidermal Growth Factor Receptor and erbB2, by a New Class of Tyrosine Kinase Inhibitor

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1998English

Epidermal Growth Factor Receptor Inhibition in Lung Cancer: The Evolving Role of Individualized Therapy

Cancer and Metastasis Reviews
Cancer ResearchOncology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy